Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A-375 | Vemurafenib | Belinostat | 0.316 | 0.000 | uM | 72 | hr | 3 | 3946 | 176 | 0.2878 | 0.2662 | 0.0446 | 0.0401 |
A-375 | Vemurafenib | Belinostat | 1.000 | 1.000 | uM | 72 | hr | 2 | 1406 | 767 | 0.0488 | 0.0489 | 0.5455 | 0.5357 |
A-375 | Vemurafenib | Belinostat | 0.100 | 0.000 | uM | 72 | hr | 1 | 6493 | 153 | 0.4841 | 0.4690 | 0.0236 | 0.0238 |
A-375 | Vemurafenib | Belinostat | 0.316 | 0.000 | uM | 72 | hr | 2 | 3734 | 151 | 0.2736 | 0.2662 | 0.0404 | 0.0401 |
A-375 | Vemurafenib | Belinostat | 1.000 | 0.000 | uM | 72 | hr | 1 | 2530 | 174 | 0.1799 | 0.1917 | 0.0688 | 0.0580 |
A-375 | Vemurafenib | Belinostat | 1.000 | 1.000 | uM | 72 | hr | 1 | 1476 | 819 | 0.0502 | 0.0489 | 0.5549 | 0.5357 |
A-375 | Vemurafenib | Belinostat | 0.000 | 0.000 | uM | 72 | hr | 3 | 14239 | 660 | 1.0368 | 1.0000 | 0.0464 | 0.0803 |
A-375 | Vemurafenib | Belinostat | 0.000 | 1.000 | uM | 72 | hr | 3 | 1361 | 489 | 0.0666 | 0.0904 | 0.3593 | 0.3077 |
A-375 | Vemurafenib | Belinostat | 0.100 | 1.000 | uM | 72 | hr | 1 | 1844 | 583 | 0.0963 | 0.0930 | 0.3162 | 0.3181 |
A-375 | Vemurafenib | Belinostat | 0.316 | 0.000 | uM | 72 | hr | 1 | 3222 | 114 | 0.2373 | 0.2662 | 0.0354 | 0.0401 |
A-375 | Vemurafenib | Belinostat | 0.316 | 1.000 | uM | 72 | hr | 2 | 1518 | 625 | 0.0682 | 0.0676 | 0.4117 | 0.4031 |
A-375 | Vemurafenib | Belinostat | 0.316 | 1.000 | uM | 72 | hr | 3 | 1432 | 626 | 0.0615 | 0.0676 | 0.4372 | 0.4031 |
A-375 | Vemurafenib | Belinostat | 1.000 | 0.000 | uM | 72 | hr | 2 | 2723 | 167 | 0.1952 | 0.1917 | 0.0613 | 0.0580 |
A-375 | Vemurafenib | Belinostat | 1.000 | 0.000 | uM | 72 | hr | 3 | 2740 | 120 | 0.2000 | 0.1917 | 0.0438 | 0.0580 |
A-375 | Vemurafenib | Belinostat | 0.000 | 0.000 | uM | 72 | hr | 1 | 13881 | 1351 | 0.9567 | 1.0000 | 0.0973 | 0.0803 |
A-375 | Vemurafenib | Belinostat | 0.000 | 0.000 | uM | 72 | hr | 2 | 14602 | 1419 | 1.0065 | 1.0000 | 0.0972 | 0.0803 |
A-375 | Vemurafenib | Belinostat | 0.000 | 1.000 | uM | 72 | hr | 1 | 2048 | 485 | 0.1193 | 0.0904 | 0.2368 | 0.3077 |
A-375 | Vemurafenib | Belinostat | 0.000 | 1.000 | uM | 72 | hr | 2 | 1660 | 543 | 0.0853 | 0.0904 | 0.3271 | 0.3077 |
A-375 | Vemurafenib | Belinostat | 0.100 | 0.000 | uM | 72 | hr | 2 | 6037 | 198 | 0.4458 | 0.4690 | 0.0328 | 0.0238 |
A-375 | Vemurafenib | Belinostat | 0.100 | 0.000 | uM | 72 | hr | 3 | 6342 | 95 | 0.4770 | 0.4690 | 0.0150 | 0.0238 |
A-375 | Vemurafenib | Belinostat | 0.100 | 1.000 | uM | 72 | hr | 2 | 1843 | 570 | 0.0972 | 0.0930 | 0.3093 | 0.3181 |
A-375 | Vemurafenib | Belinostat | 0.100 | 1.000 | uM | 72 | hr | 3 | 1672 | 550 | 0.0857 | 0.0930 | 0.3289 | 0.3181 |
A-375 | Vemurafenib | Belinostat | 0.316 | 1.000 | uM | 72 | hr | 1 | 1495 | 539 | 0.0730 | 0.0676 | 0.3605 | 0.4031 |
A-375 | Vemurafenib | Belinostat | 3.160 | 0.000 | uM | 72 | hr | 1 | 2164 | 160 | 0.1530 | 0.1495 | 0.0739 | 0.0897 |
A-375 | Vemurafenib | Belinostat | 1.000 | 1.000 | uM | 72 | hr | 3 | 1267 | 642 | 0.0477 | 0.0489 | 0.5067 | 0.5357 |